CA1224142A - Compose de facteur de transfert et traitement de la peau - Google Patents

Compose de facteur de transfert et traitement de la peau

Info

Publication number: CA1224142A
Authority: CA; Canada
Prior art keywords: transfer factor; topical composition; composition; penetrant; topical
Prior art date: 1984-03-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000448859A

Other languages

English (en)

Inventor

Stanley L. Warren

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Viragen Inc

Original Assignee

Viragen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-03-05

Filing date

1984-03-05

Publication date

1987-07-14

1984-03-05 Application filed by Viragen Inc filed Critical Viragen Inc

1984-03-05 Priority to CA000448859A priority Critical patent/CA1224142A/fr

1987-07-14 Application granted granted Critical

1987-07-14 Publication of CA1224142A publication Critical patent/CA1224142A/fr

Status Expired legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 39
108010074506 Transfer Factor Proteins 0.000 title claims abstract description 32
238000011282 treatment Methods 0.000 title claims abstract description 17
230000000699 topical effect Effects 0.000 claims abstract description 28
208000009889 Herpes Simplex Diseases 0.000 claims abstract description 6
239000002537 cosmetic Substances 0.000 claims abstract description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 17
229920002307 Dextran Polymers 0.000 claims description 7
231100000252 nontoxic Toxicity 0.000 claims description 6
230000003000 nontoxic effect Effects 0.000 claims description 6
230000002708 enhancing effect Effects 0.000 claims description 5
206010040882 skin lesion Diseases 0.000 abstract description 4
231100000444 skin lesion Toxicity 0.000 abstract description 4
206010059313 Anogenital warts Diseases 0.000 abstract description 3
208000002874 Acne Vulgaris Diseases 0.000 abstract description 2
206010000496 acne Diseases 0.000 abstract description 2
229940000033 dermatological agent Drugs 0.000 abstract 1
230000003902 lesion Effects 0.000 description 12
210000004027 cell Anatomy 0.000 description 8
238000000034 method Methods 0.000 description 7
239000002674 ointment Substances 0.000 description 6
229920000742 Cotton Polymers 0.000 description 5
239000006285 cell suspension Substances 0.000 description 4
210000004698 lymphocyte Anatomy 0.000 description 4
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 3
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
239000012530 fluid Substances 0.000 description 3
230000000306 recurrent effect Effects 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
241000700605 Viruses Species 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
230000035876 healing Effects 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
230000007794 irritation Effects 0.000 description 2
230000003020 moisturizing effect Effects 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
210000003905 vulva Anatomy 0.000 description 2
OADSZWXMXIWZSQ-UHFFFAOYSA-N 2-bromo-2-nitropropane Chemical compound CC(C)(Br)[N+]([O-])=O OADSZWXMXIWZSQ-UHFFFAOYSA-N 0.000 description 1
241000726103 Atta Species 0.000 description 1
206010013786 Dry skin Diseases 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
239000004166 Lanolin Substances 0.000 description 1
241001307210 Pene Species 0.000 description 1
241001163743 Perlodes Species 0.000 description 1
239000004264 Petrolatum Substances 0.000 description 1
208000035415 Reinfection Diseases 0.000 description 1
125000002015 acyclic group Chemical group 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000007815 allergy Effects 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000006071 cream Substances 0.000 description 1
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
230000037336 dry skin Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
210000004392 genitalia Anatomy 0.000 description 1
239000011491 glass wool Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000011707 mineral Substances 0.000 description 1
239000012184 mineral wax Substances 0.000 description 1
239000002808 molecular sieve Substances 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000035515 penetration Effects 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
229940066842 petrolatum Drugs 0.000 description 1
235000019271 petrolatum Nutrition 0.000 description 1
239000002212 purine nucleoside Substances 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000007789 sealing Methods 0.000 description 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000013190 sterility testing Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1

Landscapes

Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

CA000448859A 1984-03-05 1984-03-05 Compose de facteur de transfert et traitement de la peau Expired CA1224142A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000448859A CA1224142A (fr)	1984-03-05	1984-03-05	Compose de facteur de transfert et traitement de la peau

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000448859A CA1224142A (fr)	1984-03-05	1984-03-05	Compose de facteur de transfert et traitement de la peau

Publications (1)

Publication Number	Publication Date
CA1224142A true CA1224142A (fr)	1987-07-14

Family

ID=4127337

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000448859A Expired CA1224142A (fr)	1984-03-05	1984-03-05	Compose de facteur de transfert et traitement de la peau

Country Status (1)

Country	Link
CA (1)	CA1224142A (fr)

1984
- 1984-03-05 CA CA000448859A patent/CA1224142A/fr not_active Expired

Similar Documents

Publication	Publication Date	Title
US4435384A (en)	1984-03-06	Transfer factor composition and skin treatment
Bosler et al.	1983	Natural distribution of the Ixodes dammini spirochete
Jones et al.	1975	Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis
US4424232A (en)	1984-01-03	Treatment of herpes simplex
MILLER et al.	1978	Failure of Chloroquine in Human Babesiosis (Babesia microti) Case Report and Chemotherapeutic Trials in Hamsters
US5811089A (en)	1998-09-22	Pharmaceutical preparation based on fetal suspension and methods of treating acquired immune deficiency syndrome (HIV injection)
Morrison	1979	Chikungunya fever
Kucan	1995	Use of Biobrane in the treatment of toxic epidermal necrolysis
Van Heerden et al.	1983	Treatment and thrombocyte levels in experimentally induced canine ehrlichiosis and canine babesiosis
US4801444A (en)	1989-01-31	Medicinal preparation for individual prevention of venereal diseases and treatment of urogenital trichomoniasis
Dickerson et al.	1985	Experimental intraperitoneal infection of channel catfish, Ictalurus punctatus (Rafinesque), with Ichthyophthirius multifiliis (Fouquet).
WO2012104355A1 (fr)	2012-08-09	Agent antiviral contenant des lectines du gui recombinantes
Ko et al.	1987	Four documented cases of eosinophilic meningoencephalitis due to Angiostrongylus cantonensis in Hong Kong
HARTOFILAKIDIS-GAROFALIDIS	1969	Cystic tuberculosis of the patella: report of three cases
KR960011231B1 (ko)	1996-08-21	인체 백혈구 인터페론 및 침투 향상제를 함유하는 피부 병변 치료용 국소 조성물
KR101985087B1 (ko)	2019-05-31	사비넨을 포함하는 골격근 위축 또는 근육감소증의 예방 또는 치료용 조성물
Goebel et al.	1986	Fresh cell therapy followed by fatal coma
Bennett	1990	Medical advances consequent to the Great War 1914–1918
GB2156214A (en)	1985-10-09	Topical transfer factor compositions
Pazderová et al.	1974	Post-mortem findings and clinical signs of dimethyl mercury poisoning in man
JPH03500656A (ja)	1991-02-14	ウイルス感染の治療および予防薬剤アシル・カルニチン
DE60004481T2 (de)	2004-06-24	Behandlung von chronischer viraler infektion mit m. vaccae
JPH0676331B2 (ja)	1994-09-28	コンジローム治療用外用組成物
Müller et al.	1984	Divergent patterns of leucocyte locomotion in experimental post-traumatic osteomyelitis
Brewer	1965	Tetracycline hepatotoxicity

Legal Events

Date	Code	Title	Description
2004-07-14	MKEX	Expiry